Fig. 2: Gene alterations in the pathways more frequently altered in primary lung adenocarcinoma lacking targetable driver alterations in the RTK/RAS/RAF pathway. | British Journal of Cancer

Fig. 2: Gene alterations in the pathways more frequently altered in primary lung adenocarcinoma lacking targetable driver alterations in the RTK/RAS/RAF pathway.

From: Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies

Fig. 2

Figure downloaded from cBioPortal, representing data from the TCGA PanCancer Atlas case series, excluding cases with mutations in EGFR, ERBB2, MET, KRAS, BRAF, or fusions of ALK, NTRK1-3, RET, ROS1 (any alterations reported for these genes are represented exclusively by CNAs).

Back to article page